IA
CYTK icon

IndexIQ Advisors’s Cytokinetics CYTK Stock Holding History

IndexIQ Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$36K Buy
982
+94
+11% +$3.34K ﹤0.01% 1162
2021
Q4 		$40K Sell
888
-192
-18% -$7.41K ﹤0.01% 1125
2021
Q3 		$39K Sell
1,080
-462
-30% -$13.6K ﹤0.01% 1108
2021
Q2 		$31K Sell
1,542
-98
-6% -$2.3K ﹤0.01% 1111
2021
Q1 		$38K Buy
+1,640
New +$35K ﹤0.01% 1082

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

IndexIQ Advisors's CYTK Position: Q1 2022 in Review

IndexIQ Advisors increased its Cytokinetics (CYTK) stake by 11% in Q1 2022, buying an estimated $3.34K and bringing the position to 982 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #1162.

IndexIQ Advisors first reported a position in CYTK in Q1 2021 and has held it in 5 quarters since. The position peaked at $40K in Q4 2021. 240 funds tracked by Wall St. Rank hold CYTK as of Q1 2022.

  • IndexIQ Advisors held 982 shares of Cytokinetics worth $36K as of Q1 2022.
  • IndexIQ Advisors bought 94 Cytokinetics shares in Q1 2022, an estimated $3.34K.
  • Cytokinetics made up ﹤0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #1162 holding.
  • IndexIQ Advisors first reported a position in Cytokinetics in Q1 2021 and has held it in 5 quarters since.
  • IndexIQ Advisors's Cytokinetics position peaked at $40K in Q4 2021.
  • 240 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.